The Moertel Lecture Endowment Fund was established in 1995 to honor the legacy of Charles G. Moertel, MD, as the founder of the North Central Cancer Treatment Group (NCCTG), one of the three legacy groups that formed the Alliance for Clinical Trials in Oncology. Dr. Moertel was known for his dedication to high-quality clinical research that provided practice-changing evidence to benefit patient care in the community setting.

The Moertel Lecturer is an investigator whose research within the NCI National Clinical Trials Network (NCTN) has resulted in a major impact on community cancer practice. The award was made possible through generous donations from NCCTG members and industry support. The award is presented each year during the Plenary Session of the Alliance Spring Group Meeting.

All Alliance members are welcome to submit nominations for this award.


Past Award Recipients
2022 - Larry Norton, MD
2020 - Heidi Nelson, MD, FACS
2019 - Joseph A. Sparano, MD, FACP
2018 - Richard A. Larson, MD
2017 - Gini F. Fleming, MD
2016 - Jan C. Buckner, MD
2015 - John C. Byrd, MD
2013 - Charles L. Loprinzi, MD
2012 - Richard M. Goldberg, MD
2010 - Lawrence H. Einhorn, MD
2009 - Stuart Grossman, MD
2008 - Rakesh K. Jain, PhD
2007 - Michael O’Connell, MD
2006 - Daniel G. Haller, MD
2005 - Ian Tannock, MD
2004 - Charles Perou, PhD
2003 - Harold P. Freeman, MD
2002 - Charles M. Balch, MD
2001 - Gabriel N. Hortobagyi, MD
2000 - Robert J. Mayer, MD
1999 - Walter J. Curran Jr, MD
1998 - Peter M. Black, MD, PhD
1997 - Jack A. Roth, MD
1996 - Donald S. Coffey, PhD
1995 - C. Kent Osborne, MD

For more information, submit inquiries to:
Niveditha Subbiah, LLM
Cancer Control Program Manager
Alliance for Clinical Trials in Oncology